Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
BioNTech commits £1bn to UK in landmark life sciences investment
BioNTech is set to invest up to £1bn in the UK over the next decade, establishing new R&D and AI hubs.
Read more
Spoonful of Technology: Sept-Oct
Take a look at the latest examples of how pharma and its partners are working together to develop technology to solve key challenges.
ABPI welcomes the UK Chancellor’s new Budget
The Association of the British Pharmaceutical Industry has expressed support for the first Labour budget in 14 years.
CDC panel backs expanded use of pneumococcal vaccines in adults
Pfizer and Merck’s pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up a new market.
Merck acquires Modifi Biosciences in $1.3bn cancer therapy deal
The acquisition strengthens Merck’s oncology portfolio as the company looks to off the expiration of the patent for pembrolizumab.
HCPs rank pharma in top sectors for trust, says Ipsos
Healthcare professionals’ trust in the pharmaceutical industry has risen since 2020, with many doctors and nurses now expressing high trust.
Boehringer pledges $5m to WHO Foundation mental health initiative
Discover how this partnership could enhance access to quality healthcare, with an emphasis on mental health services for vulnerable populations in the Americas.
Britain explores Eli Lilly’s obesity drug to tackle long-term sickness
The British government is set to explore whether Eli Lilly’s weight-loss drug could play a pivotal role in getting people back to work.
Lundbeck to acquire Longboard and potential blockbuster epilepsy drug
Lundbeck will acquire Longboard Pharmaceuticals, aiming to strengthen its portfolio with its potential blockbuster epilepsy treatment.
Loading posts...
« Previous
1
…
11
12
13
14
15
…
28
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View